Studies investigating TGF-β signaling have revealed that perturbations of the TGF-β signaling pathway, such as mutations of TGF-β receptors or Smad proteins, lead to cancer progression and are related to poor prognosis of certain types of cancer. Here, TGFB1 is linked to cancer.